Since Bcl-2 was the target of AKT signaling pathway, we checked the change of AKT activity and found that Derlin-1 positively modulate AKT phosphorylation in bladder cancer cells (Figure 4A). The gene discussed is AKT1; the disease is urinary bladder carcinoma.